| Name | Title | Contact Details |
|---|---|---|
David Baruch |
Associate General Counsel | Profile |
Healthation is a Lisle, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
CareBridge offers a patented EVV solution for personal care services, home health services, and health plan care managers. Originally launched in 2009, CareBridge has spent more than a decade refining our technology through multiple statewide rollouts.
BrightSpring Health Services is the new name for Kentucky-based ResCare, the parent company of a family of brands and services that provides both clinical and nonclinical habilitative care services for people of all ages and health and skill levels, across home and community settings. As care preferences and health care needs are changing, BrightSpring`s new name reflects the company`s evolution that began nearly two years ago to successfully meet the multifaceted and multidisciplinary requirements of the populations it serves amid this changing health care landscape. The path forward at BrightSpring is occurring through investments in capabilities, people, processes and technology to create an unprecedented and differentiated platform of innovative solutions that improve health outcomes and lower costs for complex populations and payer systems. ResCare has a rich history of more than 44 years – making a difference in the communities that it serves and helping people live their best lives. While celebrating the successful history, BrightSpring is repositioning itself for the future of health care. Its vision is to be the leading provider of comprehensive home and community-based health services to complex populations.
Discovery Laboratories, Inc. is a specialty biotechnology company focused on advancing a new standard in respiratory critical care. Discovery Labs` technology platform includes its novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant, and its proprietary drug delivery technologies being developed to enable efficient delivery of aerosolized KL4 surfactant and other inhaled therapies. Discovery Labs` strategy is initially focused on neonatology and improving the management of respiratory distress syndrome (RDS) in premature infants. Discovery Labs believes that its RDS product portfolio has the potential to become the new standard of care for RDS and, over time, enable the treatment of a significantly greater number of premature infants who could benefit from surfactant therapy that are currently not being treated. In many pulmonary diseases, including RDS, acute lung injury (ALI), and other respiratory conditions, surfactant is either deficient or may fail to function properly. Our precision-engineered, peptide-containing KL4 surfactant has been designed to mimic the essential function of human pulmonary surfactant and may have the potential to address conditions such as these. We are developing our proprietary delivery technologies to one day enable efficient, targeted upper-respiratory or alveolar delivery of our KL4 surfactant in aerosolized form to allow for a gentler, less invasive delivery approach. These same delivery systems may also potentially be used to deliver a variety of additional aerosolized medicines safely and in a simplified way compared with the current standard of care.
Teleflex Medical OEM is a Kenosha, WI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.